Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors

Class III β-tubulin (TUBB3) and Topoisomerase-II (topo-II) are considered to be the predictors of therapeutic efficacy and outcome in several types of human neoplasm. However, whether TUBB3 or topo-II may predict the response to combination chemotherapy and prognosis in patients with advanced thymic...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yosuke, Kaira, Kyoichi, Sakurai, Reiko, Imai, Hisao, Tomizawa, Yoshio, Sunaga, Noriaki, Minato, Koichi, Hisada, Takeshi, Oyama, Tetsunari, Yamada, Masanobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530002/
https://www.ncbi.nlm.nih.gov/pubmed/28789453
http://dx.doi.org/10.3892/ol.2017.6419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530002/
https://www.ncbi.nlm.nih.gov/pubmed/28789453
http://dx.doi.org/10.3892/ol.2017.6419

Ejemplares similares